225 related articles for article (PubMed ID: 9381523)
1. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
Lipkin GW; Thuraisingham R; Dawnay AB; Harwood SM; Raine AE
Transplantation; 1997 Oct; 64(7):1007-17. PubMed ID: 9381523
[TBL] [Abstract][Full Text] [Related]
2. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
Lipkin GW; Dawnay AB; Harwood SM; Cattell WR; Raine AE
Kidney Int; 1997 Sep; 52(3):792-801. PubMed ID: 9291201
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
Motwani JG; Lang CC; Cramb G; Struthers AD
Hypertension; 1995 Apr; 25(4 Pt 1):637-42. PubMed ID: 7721409
[TBL] [Abstract][Full Text] [Related]
4. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
5. Renal response to candoxatrilat in patients with heart failure.
Good JM; Peters M; Wilkins M; Jackson N; Oakley CM; Cleland JG
J Am Coll Cardiol; 1995 May; 25(6):1273-81. PubMed ID: 7722120
[TBL] [Abstract][Full Text] [Related]
6. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
7. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
8. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
[TBL] [Abstract][Full Text] [Related]
9. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.
Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H
Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
Scott JM; Barclay PL; Shepperson NB
Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
[TBL] [Abstract][Full Text] [Related]
11. Renal haemodynamic, hormonal and excretory effects of low-dose atrial natriuretic factor infusion in renal transplant recipients.
Lipkin GW; Dawnay AB; Harwood SM; Kendall RG; Cattell WR; Raine AE
Clin Sci (Lond); 1992 Feb; 82(2):119-26. PubMed ID: 1311648
[TBL] [Abstract][Full Text] [Related]
12. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
14. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
Lisy O; Jougasaki M; Schirger JA; Chen HH; Barclay PT; Burnett JC
Am J Physiol; 1998 Sep; 275(3):F410-4. PubMed ID: 9729514
[TBL] [Abstract][Full Text] [Related]
15. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
17. Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
Regamey F; Maillard M; Nussberger J; Brunner HR; Burnier M
Hypertension; 2002 Sep; 40(3):266-72. PubMed ID: 12215465
[TBL] [Abstract][Full Text] [Related]
18. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL
Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
